In modern dermatological formulations and advanced cosmeceutical manufacturing, purchasing Azelaic Acid (CAS 123-99-9) and Alpha Hydroxy Acids (AHAs, such as Glycolic Acid CAS 79-14-1 and Lactic Acid CAS 72-17-3) together has emerged as a gold-standard chemical procurement strategy. While historically considered distinct therapeutic agents, modern biochemical research proves that combining dicarboxylic acids with alpha-hydroxy carboxylic acids yields a synergistic mechanism of action that significantly improves transdermal efficacy, speeds up cell turnover, and manages post-inflammatory hyperpigmentation (PIH) far more effectively than single-agent formulations.
AHAs act primarily on the stratum corneum by ionically weakening calcium-dependent desmosomal bonds between corneocytes. This targeted desquamation reduces cohesion, clearing hyperkeratotic build-up and opening intercellular pathways for deeper active penetration.
Azelaic acid acts as a competitive inhibitor of tyrosinase, directly downregulating hyperactive melanocytes without altering normal pigmentation. Concurrently, it inhibits 5-alpha-reductase and reduces oxidative stress within mitochondrial membranes.
Azelaic Acid inherently suffers from low water solubility (~0.24% at 20°C). Pre-treating or co-formulating with low-pH AHAs lowers the barrier voltage of the lipid bilayer, increasing Azelaic Acid dermal bioavailability by up to 2.4-fold.
| Active Ingredient | CAS Number | Molecular Weight | Optimal pH Range | Primary Industrial Role | Synergy Metric |
|---|---|---|---|---|---|
| Azelaic Acid | 123-99-9 | 188.22 g/mol | 4.0 - 5.5 | Anti-inflammatory, Tyrosinase Inhibition | Reduces Erythema & PIH |
| Glycolic Acid | 79-14-1 | 76.05 g/mol | 3.2 - 3.8 | Corneocyte Desquamation, Collagen Synthesis | Enhances Transdermal Flux |
| Lactic Acid | 72-17-3 (Sodium Salt) | 90.08 g/mol | 3.5 - 4.5 | Humectant Exfoliation, NMF Support | Buffers Barrier Disruption |
| Tranexamic Acid | 1197-18-8 | 157.21 g/mol | 5.0 - 6.5 | Plasminogen Inhibitor, Anti-pigment | Tri-Active Brightening Complex |
Formulating stable systems containing both Azelaic Acid and AHAs presents significant physical chemistry challenges. Azelaic acid exhibits a high melting point (106.5°C) and tends to recrystallize into gritty agglomerates in conventional aqueous gels. Concurrently, AHAs require a low pH to maintain un-dissociated acid molecules for biological activity.
To prevent graininess, modern industrial chemistry utilizes specialised eco-friendly solvents such as Solketal (CAS 100-79) and 3-Methoxy-3-Methyl-1-Butanol (MMB, CAS 56539-66-3). Integrating these solvents yields crystal-clear microemulsions while stabilizing the overall pH profile.
The next-generation R&D roadmap focuses on dual-stage microencapsulation. Using bio-polymers like Hydroxyapatite (CAS 1306-06-5) and sucrose-based emulsifiers, active ingredients are delivered sequentially:
Implementation of Solketal-based isotropic clear gels.
Dual targeted delivery with reduced stinging potential.
Micro-fluidic reactor production ensuring 99.8% purity profiles.
As global demand for dual-acid corrective cosmetics scales rapidly across North America, Europe, and the Asia-Pacific region, international B2B buyers require reliable manufacturing partners. JIMPOCHEM CO., LTD provides end-to-end chemical manufacturing, raw material synthesis, and global export support from its state-of-the-art industrial park.
Headquartered in the Chemical Industry Park of Jinan City, Shandong Province, JIMPOCHEM operates fully automated, digitalized production lines balancing massive bulk chemical orders with specialized, low-MOQ cosmetic grade customization.
Every batch of Azelaic Acid, Glycolic Acid, and auxiliary fine chemicals undergoes complete testing via HPLC, GC-MS, and ICP-OES. Full batch traceability allows buyers to review raw material origins, process telemetry, and third-party inspection data.
In compliance with global ESG standards, our facility utilizes zero-emission waste residue conversion systems and low-carbon catalytic hydrogenation processes, ensuring regulatory compliance for downstream multinational brands.
JIMPOCHEM CO., LTD was established in 2010 and is headquartered in the Chemical Industry Park of Jinan City, Shandong Province. The company covers an area of over 500 acres and is a professional chemical raw material manufacturer that integrates research and development, production, sales, and technical services. Its core focus is on high-end fine chemicals and cosmetic raw materials. We have obtained multiple product-related certifications, including ISO quality system certification and environmental management system certification, and are committed to providing high-quality chemical products and one-stop procurement service solutions to global customers.
Our core team comprises experts with over 10 years of experience in the chemical industry. This enables us not only to provide professional products but also to offer solutions in product development, formula optimization, and supply chain management, meeting the personalized needs of diverse clients. We provide high-quality products and services, and our products are exported to over 200 countries and regions in Europe, America, Southeast Asia, the Middle East, and Oceania, serving more than 5,000 international companies.
Adhering to the philosophy that "quality is the lifeline of an enterprise," we have established long-term strategic partnerships with many internationally renowned chemical companies, becoming a trusted "designated chemical service provider" for numerous clients.
Purchasing chemical raw materials for global markets requires navigating strict regional regulatory frameworks. JIMPOCHEM provides full dossier technical packages including Safety Data Sheets (SDS), Certificates of Analysis (COA), REACH registration, and GMP documentation tailored to international markets.
Under the Modernization of Cosmetics Regulation Act (MoCRA), OTC acne treatments combining Azelaic Acid with AHAs require strict facility registration and safety substantiation. Over-the-counter strengths (up to 10% Azelaic Acid) must comply with monograph guidelines.
The Scientific Committee on Consumer Safety (SCCS) limits leave-on AHA concentrations while maintaining strict purity limits for heavy metals and trace impurities in dicarboxylic acids. Our products conform fully to EU Regulation (EC) No 1223/2009.
China's National Medical Products Administration (NMPA) mandates exact ingredient safety disclosures for Ordinary Cosmetic Notifications. JIMPOCHEM raw materials are pre-registered with complete safety data codes for seamless brand filing.
Facial serums, corrective chemical peels, hyperpigmentation creams, anti-acne spot treatments, and exfoliating cleansers.
Prescription-strength rosacea treatments (15-20% gel systems), active pharmaceutical intermediates, and medical-grade skin barrier repair bases.
Polymer synthesis additives, plasticizers, electronics clearing fluids, fluorine-based solvents, and high-performance lubricants.
In addition to core dicarboxylic acids and hydroxy acids, JIMPOCHEM produces and exports an extensive catalog of organic intermediates, functional cosmetic agents, surfactants, and specialty fluorine compounds.
JIMPOCHEM